MediHumdani's profile picture. BMT & Cellular Therapy | Secretary @ASTCT | Co-Chair @ASTCT CoPG | #bmtsm #CARTcell #lymsm | Personal views | Doctor not Provider | 🇵🇰 🏏 🇺🇸  🏈

Mehdi Hamadani, MD

@MediHumdani

BMT & Cellular Therapy | Secretary @ASTCT | Co-Chair @ASTCT CoPG | #bmtsm #CARTcell #lymsm | Personal views | Doctor not Provider | 🇵🇰 🏏 🇺🇸 🏈

Pinned

The story of my CART pt as painted by her continues. Her latest (bottom right) shows ongoing need for neutrophils 2 years post #CART #lymsm Her prior work in thread below @MCWCancerCenter

MediHumdani's tweet image. The story of my CART pt as painted by her continues. Her latest (bottom right) shows ongoing need for neutrophils 2 years post #CART #lymsm
Her prior work in thread below @MCWCancerCenter
MediHumdani's tweet image. The story of my CART pt as painted by her continues. Her latest (bottom right) shows ongoing need for neutrophils 2 years post #CART #lymsm
Her prior work in thread below @MCWCancerCenter

Mehdi Hamadani, MD reposted

Thank you to everyone who joined us in NYC for last night’s State of the Science Summit™! Dr. Mailankody, @MCThompsonMD, @PallawiTorkaMD, @szusmani & @MediHumdani led a dynamic program on the latest in hematologic malignancies. Explore upcoming events: hubs.li/Q03V3b_h0

OncLive's tweet image. Thank you to everyone who joined us in NYC for last night’s State of the Science Summit™! Dr. Mailankody, @MCThompsonMD, @PallawiTorkaMD, @szusmani & @MediHumdani led a dynamic program on the latest in hematologic malignancies. 
Explore upcoming events: hubs.li/Q03V3b_h0

Probably the first evidence of 19CART in intravascular large B-cell lymphoma: N=9; CR rate = 66%; One-year NRM, relapse/progression, PFS, and OS were 0%, 71.4%, 28.6%, and 50%, respectively #lymsm Early View | Haematologica haematologica.org/article/view/1…


2025 still Perfectly ok to be openly racist against Muslims. What’s new?

Remember to vote tomorrow in New York! Bear in mind that a vote for Curtis is really a vote for Mumdumi or whatever his name is. VOTE CUOMO!



Mehdi Hamadani, MD reposted
packers's tweet image.

Mehdi Hamadani, MD reposted

HE DOES THIS 😤 📺: NBC


Mehdi Hamadani, MD reposted

Sack attack


Mehdi Hamadani, MD reposted

JACOBS TD! Stay 'til the end for a surprise 📺: CBS


Mehdi Hamadani, MD reposted

☀️ Sunshine State Sunday Spotlight! Heading to #ASH25 in Orlando? Start early with Medical Crossfire®: Navigating Chronic GVHD Prophylaxis and Treatment 📅 Dec 5 |📍Orlando, FL ✨ Don’t miss out! Register: hubs.li/Q03N8Vdv0 Speakers: @DrCCutler @MediHumdani @AnnaSureda5


Mehdi Hamadani, MD reposted

𝐖𝐞’𝐫𝐞 𝐤𝐢𝐜𝐤𝐢𝐧𝐠 𝐨𝐟𝐟 𝐭𝐡𝐞 𝐂𝐎𝐋𝐘𝐌 𝐭𝐫𝐚𝐜𝐤 𝐚𝐭 #IACH2025! 𝐍𝐨𝐰 𝐥𝐢𝐯𝐞: 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐒𝐞𝐬𝐬𝐢𝐨𝐧 🎤 𝘔𝘰𝘥𝘦𝘳𝘢𝘵𝘰𝘳𝘴: 𝘚𝘵𝘦𝘧𝘢𝘯𝘰 𝘓𝘶𝘮𝘪𝘯𝘢𝘳𝘪 & 𝘈𝘯𝘯𝘢 𝘚𝘶𝘳𝘦𝘥𝘢 Starting now — join the live broadcast: iach.cme-congresses.com

TheIACH's tweet image. 𝐖𝐞’𝐫𝐞 𝐤𝐢𝐜𝐤𝐢𝐧𝐠 𝐨𝐟𝐟 𝐭𝐡𝐞 𝐂𝐎𝐋𝐘𝐌 𝐭𝐫𝐚𝐜𝐤 𝐚𝐭 #IACH2025!

𝐍𝐨𝐰 𝐥𝐢𝐯𝐞: 𝐆𝐞𝐧𝐞𝐫𝐚𝐥 𝐒𝐞𝐬𝐬𝐢𝐨𝐧

🎤 𝘔𝘰𝘥𝘦𝘳𝘢𝘵𝘰𝘳𝘴: 𝘚𝘵𝘦𝘧𝘢𝘯𝘰 𝘓𝘶𝘮𝘪𝘯𝘢𝘳𝘪 & 𝘈𝘯𝘯𝘢 𝘚𝘶𝘳𝘦𝘥𝘢

Starting now — join the live broadcast:
iach.cme-congresses.com…

Mehdi Hamadani, MD reposted

Brandon McManus drills the 53-yard FG to send the Packers-Cowboys game to OT 🔥

From NFL

What a game! #GoPackGo

HEADED TO OVERTIME

packers's tweet image. HEADED TO OVERTIME


Mehdi Hamadani, MD reposted

Romeo Doubs REELS it in for his second TD of the game 😤

From NFL

Mehdi Hamadani, MD reposted

We spoke with BCT Co-Editor-in-Chief @MediHumdani (@MedicalCollege) on whether clinicians should use FLT3 inhibitor maintenance in FLT3-ITD #AML based on the MORPHO study, and how MRD helps inform that decision. 📺 Watch here! buff.ly/6KHeGiH

Blood_Cancers's tweet image. We spoke with BCT Co-Editor-in-Chief @MediHumdani (@MedicalCollege) on whether clinicians should use FLT3 inhibitor maintenance in FLT3-ITD #AML based on the MORPHO study, and how MRD helps inform that decision.

📺 Watch here! buff.ly/6KHeGiH

Mehdi Hamadani, MD reposted

⏰ 𝗧𝗵𝗲 𝗜𝗔𝗖𝗛 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗱𝗮𝘆𝘀 𝗮𝗿𝗲 𝗷𝘂𝘀𝘁 𝗮𝗿𝗼𝘂𝗻𝗱 𝘁𝗵𝗲 𝗰𝗼𝗿𝗻𝗲𝗿! Explore the exciting program & faculty: iach.cme-congresses.com/program/ 📅 October 9–11, 2025 Join us in Paris or online! @Mohty_EBMT @doctorpemm @nagler_EBMT @Santin13Valeria @Dr_AmerZeidan

TheIACH's tweet image. ⏰ 𝗧𝗵𝗲 𝗜𝗔𝗖𝗛 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝗱𝗮𝘆𝘀 𝗮𝗿𝗲 𝗷𝘂𝘀𝘁 𝗮𝗿𝗼𝘂𝗻𝗱 𝘁𝗵𝗲 𝗰𝗼𝗿𝗻𝗲𝗿!

Explore the exciting program & faculty:
iach.cme-congresses.com/program/

📅 October 9–11, 2025

Join us in Paris or online!

@Mohty_EBMT @doctorpemm @nagler_EBMT @Santin13Valeria @Dr_AmerZeidan…

Mehdi Hamadani, MD reposted

Important mechanistic study on ICAHT from our French colleagues @GustaveRoussy highlighting that lymphodepletion alone is insufficient to explain prolonged cytopenia after CART …a second inflammation / CAR-mediated hit within the BM is needed 👆 science.org/doi/pdf/10.112…


Mehdi Hamadani, MD reposted

Largest multicenter real-world analysis to date from CIBMTR shows CD19 CAR T-cell therapy yields high response rates & durable remissions in PMBCL with low rates of severe toxicities #lymphoma doi.org/10.1002/ajh.70… @drjgauthier @MediHumdani

AjHematology's tweet image. Largest multicenter real-world analysis to date from CIBMTR shows CD19 CAR T-cell therapy yields high response rates & durable remissions in PMBCL with low rates of severe toxicities #lymphoma
doi.org/10.1002/ajh.70…
@drjgauthier @MediHumdani

Mehdi Hamadani, MD reposted

Our latest publication in #Hematology aimed at exploring the #disparities in #ITP-related #mortality in the #USA, highlighting inequities that warrant systemic change. #globalhealth #HealthEquity @WeAreTandF tandfonline.com/doi/full/10.10…

mshahzadmd's tweet image. Our latest publication in #Hematology aimed at exploring the #disparities in #ITP-related #mortality in the #USA, highlighting inequities that warrant systemic change.  #globalhealth #HealthEquity @WeAreTandF tandfonline.com/doi/full/10.10…

Mehdi Hamadani, MD reposted

Just out @ASTCT journal. CART for Richter's transformation led by @NadimintiHOBMT ! @CIBMTR @MediHumdani #CLL @fredhutch

Chimeric Antigen Receptor T-cell Therapy for Richter Transformation: A CIBMTR analysis - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy astctjournal.org/article/S2666-… @MediHumdani @mshadman



Loading...

Something went wrong.


Something went wrong.